Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation

28 Apr 2006

Abstract excerpt

Because of their ability to proliferate and to differentiate into diverse cell types, embryonic stem (ES) cells are a potential source of cells for transplantation therapy of various diseases, including Parkinson's disease. A critical issue for this potential therapy is the elimination of undifferentiated cells that, even in low numbers, could result in teratoma formation in the host brain. We hypothesize that an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenesis and neuroplasticity mechanisms
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16696855
DOI: 10.1111/j.1471-4159.2006.03841.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantationPMID 16696855Read ↗

Stem cells for neurodegenerative disorders: where can we go from here?Semantic proximity Read ↗

Lineage-selective suicide gene system enables post-engraftment editing of cell therapy compositionSemantic proximity Read ↗

Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells.Semantic proximity Read ↗

High-purity lineage selection of embryonic stem cell-derived neurons.Semantic proximity Read ↗

Stem-Cell-Based Strategies for the Treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Analysis of in vitro and in vivo characteristics of human embryonic stem cell-derived neural precursors.Semantic proximity Read ↗

Stem cell therapy for Parkinson’s disease: safety and modelingSemantic proximity Read ↗

Advancing Parkinson’s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cellsSemantic proximity Read ↗

Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s diseaseSemantic proximity Read ↗

Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.Semantic proximity Read ↗

CD133 Expression by Neural Progenitors Derived from Human Embryonic Stem Cells and Its Use for Their Prospective IsolationSemantic proximity Read ↗

High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.